Mounjaro proves more heart protective than Trulicity in trial of Eli Lilly diabetes drugs

Mounjaro is the company's diabetes drug that targets the GLP-1 protein and is also used for weight loss. In the U.S., the obesity version is sold under the brand name Zepbound.